{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:37:52Z","timestamp":1790257072915,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002540","name":"Namseoul University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003182","name":"Siberian Branch, Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009770","name":"National University of Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.neulet.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T10:12:22Z","timestamp":1512209542000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Suppression of autophagy in the brain of transgenic mice with overexpression of \u041053\u0422-mutant \u03b1-synuclein as an early event at synucleinopathy progression"],"prefix":"10.1016","volume":"672","author":[{"given":"Alexander B.","family":"Pupyshev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Korolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Akopyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara G.","family":"Amstislavskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Tikhonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.12.001_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/7854_2014_355","article-title":"Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits","volume":"22","author":"Hatami","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fnins.2015.00503","article-title":"Evaluation of models of Parkinson's disease","volume":"9","author":"Jagmag","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2017.12.001_bib0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4161\/auto.7.4.14393","article-title":"The Parkinson disease protein alpha-synuclein inhibits autophagy","volume":"7","author":"Winslow","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.neulet.2017.12.001_bib0025","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0030","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","article-title":"Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy","volume":"4","author":"Xilouri","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s12035-014-8933-0","article-title":"Crosstalk between macroautophagy and chaperone-mediated autophagy: implications for the treatment of neurological diseases","volume":"52","author":"Wu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2017.12.001_bib0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and alpha-synuclein: relevance to parkinson's disease and related synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2017.12.001_bib0045","doi-asserted-by":"crossref","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","article-title":"The role of autophagy in Parkinson's disease","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neulet.2017.12.001_bib0050","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2017.12.001_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JHD-130081","article-title":"Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice","volume":"3","author":"Vodicka","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neulet.2017.12.001_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbr.2017.05.002","article-title":"Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence","volume":"330","author":"Tikhonova","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2017.12.001_bib0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/187152710791556177","article-title":"alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach","volume":"9","author":"Bazzu","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neulet.2017.12.001_bib0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2017.12.001_bib0075","doi-asserted-by":"crossref","first-page":"e60378","DOI":"10.1371\/journal.pone.0060378","article-title":"Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function","volume":"8","author":"Oaks","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.12.001_bib0080","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease","volume":"8","author":"Paumier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.12.001_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JPD-120130","article-title":"Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice","volume":"3","author":"Rothman","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neulet.2017.12.001_bib0090","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0095","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.12.001_bib0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12035-014-8738-1","article-title":"Overexpression of human E46\u202fK mutant alpha-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway","volume":"50","author":"Yan","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2017.12.001_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68","author":"Savolainen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2017.12.001_bib0110","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2192 the mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2017.12.001_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13000-016-0459-5","article-title":"Beclin1 and HMGB1 ameliorate the alpha-synuclein-mediated autophagy inhibition in PC12 cells","volume":"11","author":"Wang","year":"2016","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.neulet.2017.12.001_bib0120","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2017.12.001_bib0130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","article-title":"A53T human alpha-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration","volume":"35","author":"Chen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.12.001_bib0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/187152712800792910","article-title":"Current status of tyrosine hydroxylase in management of Parkinson's disease","volume":"11","author":"Feve","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neulet.2017.12.001_bib0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","article-title":"Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice","volume":"21","author":"Unger","year":"2006","journal-title":"Neurobiol. Dis."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017309746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017309746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T22:58:04Z","timestamp":1656370684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017309746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":28,"alternative-id":["S0304394017309746"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.12.001","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of autophagy in the brain of transgenic mice with overexpression of \u041053\u0422-mutant \u03b1-synuclein as an early event at synucleinopathy progression","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}